Announcement 31 August 2021
'Dr Kylie Sandy‐Hodgetts, Senior Research Fellow at the School of Biomedical Sciences, UWA, and principal investigator on the study said, “Based on the encouraging results from the phase 1 study in healthy volunteers, we are now preparing for a study in patients with established scars. We will be investigating the safety of 3 months’ treatment with PXS‐6302, and exploring if 3 months’ treatment with PXS‐6302, at a dose that we now know will significantly inhibit an enzyme implicated in scar formation, can make a difference to both the appearance and structure of their scars.”'
News out shortly I guess
Ann: Response to ASX Aware Query, page-3
Add SNT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
3.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $41.29M | |||
| Open | High | Low | Value | Volume |
| 3.2¢ | 3.2¢ | 3.1¢ | $3.013K | 94.94K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 1312434 | 3.1¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 3.2¢ | 166468 | 3 |
View Market Depth
| Last trade - 10.45am 16/08/2024 (20 minute delay) ? |
| SNT (ASX) Chart |